Breast cancer remains the most common malignant carcinoma among women globally and
is resistant to several therapeutic agents. There is a need for novel targets to improve the …

Breast cancer is one of the most common malignancies in women worldwide. Many studies
have shown that tumor microenvironment cells, immune cells, and stromal cell infiltration …

Objective: Tumor suppressor genes (TSGs) play critical roles in the cell cycle checkpoints
and in modulating genomic stability. Here, we aimed to develop a TSG-based prognostic …

There has been increasing attention on immune-oncology for its impressive clinical benefits
in many different malignancies. However, due to molecular and genetic heterogeneity of …

Breast carcinoma (BRCA) is the most common carcinoma among women worldwide.
Despite the great progress achieved in early detection and treatment, morbidity and mortality …

Breast cancer accounts for nearly half of all cancer-related deaths in women worldwide.
However, the molecular mechanisms that lead to tumour development and progression …

Breast cancer is the most frequently diagnosed cancer and the second leading cause of
cancer death among women worldwide. Therefore, the need for effective breast cancer …

Breast cancer (BC) is the most commonly diagnosed cancer and the leading cause of death
in women. Researchers have discovered an increasing number of molecular targets for BC …

Breast cancer is one of the most common cancers. Although the present molecular
classification improves the treatment effect and prognosis of breast cancer, the …

Breast cancer (BC) is the most malignant tumor in women. The molecular mechanisms
underlying tumorigenesis still need to be further elucidated. It is necessary to investigate …